Regulation of Pulmonary Inflammation

肺部炎症的调节

• 批准号: 7891335
• 负责人: PETER M HENSON
• 金额: $ 52.47万
• 依托单位: NATIONAL JEWISH HEALTH
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-07-01 至 2013-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7891335
• 关键词: Address; Adjuvant; Anti-Inflammatory Agents; Anti-inflammatory; Antigens; Apoptosis; Apoptotic; Asthma; Autoimmune Responses; Autoimmunity; Binding; Cell membrane; Cells; Development; Disease; Environment; Event; Excision; Grant; Hand; Hypersensitivity; Immune; Immune response; Immunologics; Immunosuppression; Immunosuppressive Agents; In Vitro; Inflammation; Inflammatory; Inflammatory Response; Investigation; Knowledge; Lead; Ligands; Liposomes; Lung; Mediating; Membrane; Mus; Nature; Necrosis; Phagocytes; Phagocytosis; Phosphatidylserines; Pilot Projects; Pneumonia; Population; Process; Reaction; Recruitment Activity; Regulation; Resolution; Role; Signal Pathway; Staging; System; T-Lymphocyte; Time; Tissues; Transforming Growth Factor beta; Work; immunogenicity; in vivo; novel; novel strategies; pathogen; phosphatidylserine receptor; prevent; receptor; response; subcutaneous; uptake

Recognition and removal of apoptotic cells is a critically important and highly conserved biologic process that is ?silent? with regard to local tissue responses. We have previously shown that the apoptotic cells induce an active anti-inflammatory response that is mediated in large part by the redistribution of phosphatidylserine (PS) from the inner to the outer leaflet of the plasma membrane and its subsequent recognition by responding phagocytes and other cells. More recently we have shown that PS on the apoptotic cells can also suppress the adaptive immune response. In the lung, as elsewhere in the body, these effects are suggested to mediate the resolution of normal, protective and self-limited inflammatory responses by removing apoptotic inflammatory cells, suppressing the ongoing inflammation while at the same time preventing inappropriate immune reactions. We have also shown that much of the inflammosuppression and immunosuppression initiated by recognition of the PS is mediated through the induction and effects of transforming growth factor beta (TGFa). Nevertheless, despite the information that we and others have gathered on the role of exposed PS, we still do not have an adequate understanding of the mechanisms and particularly, the receptors that recognize and respond to the PS, especially in its ability to drive the suppressive processes. Recently a number of candidate direct ?receptors? for PS have been identified to go along with previously described bridge molecules that bind on the one hand to PS on the apoptotic cells and on the other to receptors on the responding phagocyte. Accordingly, we suggest that the time is now ripe for a concerted approach to determine the receptors and mechanisms underlying the inflammosuppressive and immunosuppressive effects of PS-exposing apoptotic cells. These studies will be carried out in the pulmonary environment and following our usual approach will involve investigations both in vitro and in vivo. The proposal encompasses two specific aims, one on the inflammosuppression and one on immunosuppression, with major emphases on characterizing the role for TGFa and identifying the relevant receptors, first in vitro and then in vivo as well as exploring novel mechanisms by which immune responses in the lung are modulated. Implications and broader objectives of this work are the ability to use the knowledge obtained to deliberately block ongoing inflammatory and/or immunologic reactions in the lung and indeed the proposal includes early studies to explore this potential.

凋亡细胞的识别和清除是一个非常重要且高度保守的生物学过程